COMMUNIQUÉS West-GlobeNewswire

Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results
20/03/2025
Potentially best-in-class RAS-targeting franchise advancing with both ERAS-0015 and ERAS-4001 expected to enter the clinic in 2025 Ongoing Phase 3 SEACRAFT-2 registrational trial progressing well with Stage 1 randomized [...]
Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
20/03/2025
Enrollment completed in Phase 2a CBeyond™ trial of CB1 inhibitor, nimacimab, in obesity and overweight Faster-than-expected enrollment enables full top-line Phase 2a data in late Q3/early Q4 2025, ahead of schedule; [...]
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025
20/03/2025
NEWTON, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic [...]
Spectral AI Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Spectral IP
20/03/2025
DALLAS, March 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”) , developer of the AI-driven DeepView ® System, which received Breakthrough Device Designation from the U.S. Food [...]
Take the Lead: Forward a New Evolution in Slide-Free Pathology with MUSE Microscopy’s Groundbreaking SmartPath Technology
20/03/2025
IRVINE, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc ., a pioneer in digital pathology innovation, is proud to announce the development of its revolutionary slide-free, digital tissue imaging platform [...]
Teclison, Inc. to Participate in Upcoming Investor Conference
20/03/2025
PRINCETON, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- Teclison, Inc., a clinical-stage oncology company dedicated to advancing immunotherapeutic treatments for solid tumors, today announced that Ray Lee, chief executive [...]
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
20/03/2025
Company announcement – No. 5 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, March 20, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no [...]
Cylinder acquires Dieta Health, AI-powered stool imaging technology, to advance AI-driven digestive care
20/03/2025
The acquisition enhances Cylinder’s diagnostic accuracy, expands clinical partnerships, and drives growth-focused trials CHICAGO, March 20, 2025 (GLOBE NEWSWIRE) -- Cylinder , the leading virtual digestive health [...]
PathAI Announces EMA Qualification for AIM-MASH AI Assist, a Groundbreaking AI Tool for MASH Clinical Trials
20/03/2025
BOSTON, March 20, 2025 (GLOBE NEWSWIRE) -- PathAI , a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted [...]
WAKE RADIOLOGY'S NEWEST MOBILE MRI UNIT IS NOW ON THE ROAD, PROVIDING GREATER ACCESS TO THE COMMUNITIES THEY SERVE WHILE DELIVERING THE LATEST IN CUTTING-EDGE TECHNOLOGY ACROSS THE TRIANGLE AREA
20/03/2025
Raleigh, N.C., March 20, 2025 (GLOBE NEWSWIRE) -- Wake Radiology has recently expanded its commitment to providing greater patient access and convenience with the rollout of the latest state-of-the-art mobile MRI unit. [...]
Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy
20/03/2025
LAUPHEIM, Germany and MILFORD, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the [...]
U.S. Oral Surgery Management Enters Wisconsin Market
20/03/2025
Adds New Partner Practices in Wisconsin and Oregon IRVING, Texas, March 20, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) – a management services organization that exclusively serves premier oral and [...]
Can-Fite Partner Vetbiolix Accelerate Piclidenoson Development with Advanced Clinical Trial for Canine Osteoarthritis in a $3.8 Billion Market
20/03/2025
Can-Fite’s upfront and royalties on sales upon regulatory approval of Piclidenoson for veterinary use, is projected to be $325 million in the aggregate over the next decade assuming a 2029 launch Ramat Gan, Israel, [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
20/03/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 20 MARCH 2025 at 15.30 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Transporting Sterile Medical Devices – AAMI Sterilization Guidance
20/03/2025
TIR109 applies to health care facilities and off-site reprocessing centers Arlington, VA, March 20, 2025 (GLOBE NEWSWIRE) -- Transportation of medical devices between facilities is increasingly the norm. Health care [...]
Precision Medicine Surge: KFSHRC Achieves 39% Rise in Genetic Mutation Analysis
20/03/2025
Advanced testing empowers tailored therapies and proactive management of hereditary diseases RIYADH, Saudi Arabia, March 20, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has [...]
Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025
20/03/2025
LAKE FOREST, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the iAccess Alpha [...]
Precision Optics Appoints Joseph P. Pellegrino, Jr. to Board of Directors
20/03/2025
GARDNER, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries [...]
Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer’s Disease
20/03/2025
Planned single, pivotal Phase 2/3 clinical trial, if positive, acceptable for Biological License Application (BLA) submission for Alzheimer’s disease Alignment with FDA on proposed trial study design, population and [...]

Pages